Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

InKine completes enrollment in phase II study of INKP-102

May 17, 2004

Potential use of antidepressants in patients with IBS

May 17, 2004

Partial clinical hold in phase IIa trial of HepeX-C

May 14, 2004

Positive results from RW study of SPI-0211 for constipation

May 13, 2004

Pfizer presents another series of 5-HT4 agonists for GI disorders

May 13, 2004

Tolevamer development advances based on study results

May 12, 2004

First portion of Entereg NDA submitted

May 12, 2004

New 5-HT4 receptor agonists prepared and tested by Pfizer scientists

May 11, 2004

Roche completes registration program for Pegasys in hepatitis B

May 7, 2004

Japanese researchers describe a potential H. pylori vaccine based on urease-derived peptide

May 7, 2004

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...